Huang, J., Guo, Y., Liang, L., Lin, L., Liang, Y., Yang, T., Guo, Z., Huang, J., Zhou, J., Zhu, K., Huang, W., Cai, M. (2026). Yttrium-90 SIRT followed by lenvatinib plus sintilimab for unresectable intermediate-to-advanced hepatocellular carcinoma: Phase II SIRLENS-90 trial.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.4149